HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IFF

This article was originally published in The Rose Sheet

Executive Summary

Lower consumption and inventory correction drives "sharp decline" in firm's fine fragrance and beauty care business, International Flavors and Fragrances says in an April 30 first quarter earnings release. Sales for fragrances were down 9% on a reported basis, and down 5% on a local currency basis. North American fragrance sales increased 2%, but sales in the Europe, Africa and Middle East regions plummeted 24% (16% in local currencies), company notes. "The fragrance team continues to win key projects and is building core capabilities that we expect will lead to future growth," says Chairman and CEO Robert Amen. Impact of foreign currency translation drove total sales down 6.2% to $560 mil. Net income declined 16% to $47.2 mil

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016144

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel